![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
NAFLD and risk of incident steatohepatitis, cirrhosis and hepatocellular carcinoma
in four European primary care databases
|
|
|
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Dr William Alazawi MA(Cantab) PhD FRCP
Reader and Consultant in Hepatology
Queen Mary, University of London
![AASDL1](../images%20/041918/041918-12/AASDL1.gif)
![AASDL2](../images%20/041918/041918-12/AASDL2.gif)
![AASDL3](../images%20/041918/041918-12/AASDL3.gif)
![AASDL4](../images%20/041918/041918-12/AASDL4.gif)
![AASDL5](../images%20/041918/041918-12/AASDL5.gif)
![AASDL6](../images%20/041918/041918-12/AASDL6.gif)
![AASDL7](../images%20/041918/041918-12/AASDL7.gif)
![AASDL8](../images%20/041918/041918-12/AASDL8.gif)
![AASDL9](../images%20/041918/041918-12/AASDL9.gif)
![AASDL10](../images%20/041918/041918-12/AASDL10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|